ATYR
Atyr Pharma Inc. (ATYR)
NASDAQ · Healthcare
Atyr Pharma Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Atyr Pharma Inc. shareholder equity for the quarter ending December 31, 2025 were 67.5M, a 3.63% decrease year-over-year.
- Atyr Pharma Inc. shareholder equity for 2025 were 67.5M, a 3.63% decrease from 2024.
- Atyr Pharma Inc. shareholder equity for 2024 were 70.0M, a 22.77% decrease from 2023.
- Atyr Pharma Inc. shareholder equity for 2023 were 90.7M, a 26.86% increase from 2022.
- Atyr Pharma Inc. shareholder equity for 2022 were 71.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Atyr Pharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $67 |
| 2024 | $70 |
| 2023 | $91 |
| 2022 | $71 |
| 2021 | $109 |
| 2020 | $32 |
| 2019 | $21 |
| Atyr Pharma Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $67 |
| 2024-12-31 | $70 |
| 2023-12-31 | $91 |
| 2022-12-31 | $71 |
| 2021-12-31 | $109 |
| 2020-12-31 | $32 |
| 2019-12-31 | $21 |
Atyr Pharma Inc. Shareholder Equity — FAQ
Atyr Pharma Inc. (ATYR) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATYR's shareholder equity history?
The chart and table above show Atyr Pharma Inc.'s shareholder equity by year and by quarter, including the growth rate.